Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 936 cases

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3386-3392

  Fahim, Magid ^a,b   Hawley, Carmel M ^a,b   McDonald, Stephen P ^a,c   Brown, Fiona G ^a,d   Rosman, Johan B ^a,e   Wiggins, Kathryn J ^a,f   Bannister, Kym M ^a,g   Johnson, David W ^a,b  

^a Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e MIDDLEMORE HOSPITAL   (New Zealand)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

antibiotics; microbiology; outcomes; peritoneal dialysis; peritonitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; DICLOXACILLIN; FLUCLOXACILLIN; GENTAMICIN; METRONIDAZOLE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTERIAL PERITONITIS; CATHETER REMOVAL; COAGULASE NEGATIVE STAPHYLOCOCAL PERITONITIS; COAGULASE NEGATIVE STAPHYLOCOCCAL PERITONITIS; CONTROLLED STUDY; DEATH; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; TREATMENT DURATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; COAGULASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 77957239227     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq222     Document Type: Article

References (22)

1. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52: 524-529
2. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; S55-S62
3. Zelenitsky S, Barns L, Findlay I et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36: 1009-1013
4. Kim DK, Yoo TH, Ryu DR et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24: 424-432
5. Brown F, Liu WJ, Kotsanas D, Korman TM, Atkins RC. A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int 2007; 27: 565-574
6. Szeto CC, Kwan BC, Chow KM et al. Coagulase negative staphylo-coccal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 2008; 3: 91-97
7. Daly CD, Campbell MK, Macleod AM et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16: 341-347
8. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 2735-2746
9. Piraino B, Bailie GR, Bernardini J et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-131
10. Govindarajulu S, Hawley C, McDonald SP et al. Staphylococcus au-reus peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 503 cases. Perit Dial Int 2009; In press
11. O'Shea S, Hawley CM, McDonald SP et al. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 2009; 10: 19
12. Edey M, Hawley C, McDonald SP et al. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 2009; 25: 1272-1278
13. Barraclough K, Hawley CM, McDonald SP et al. Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant 2009; 24: 3834-3839
14. Siva B, Hawley CM, McDonald SP et al. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4: 957-964
15. Miles R, Hawley CM, McDonald SP et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622-628
16. Barraclough K, Hawley CM, McDonald SP et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 2009; 55: 121-131
17. Fahim M, Hawley CM, McDonald SP et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment and outcomes in 435 cases. Am J Kidney Dis 2009; 55: 690-697
18. Goldstein H. Multilevel Statistical Models. London: Hodder Arnold, 2003
19. Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 2006; S44-S54
20. Spare MK, Tebbs SE, Lang S et al. Genotypic and phenotypic properties of coagulase-negative staphylococci causing dialysis catheter-related sepsis. J Hosp Infect 2003; 54: 272-278
21. Amato D, de JV, Miranda G et al. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kidney Dis 2001; 37: 43-48
22. Ariano RE, Franczuk C, Fine A, Harding GK, Zelenitsky SA. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22: 335-338